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Abstract: 
A series of asymmetrically disubstituted diitaconate monomers is presented. Starting from 
itaconic anhydride, functional groups could be placed selectively at the two non-equivalent 
carbonyl groups. Using 2D NMR, it was shown that the first functionalization step occurred at 
the carbonyl in -position to the double bond. These monomers were copolymerized with 
dimethylacrylamide (DMAA) to yield polymer-based synthetic mimics of antimicrobial 
peptides (SMAMPs). They were obtained by free radical polymerization, a metal free process, 
and still maintained the facial amphiphilicity at the repeat unit level. This eliminates the need 
for laborious metal removal and is advantageous from a regulatory and product safety 
perspective. 
The poly(diitaconate-co-DMAA) copolymers obtained were statistical to alternating, and the 
monomer feed ratio roughly matched the repeat unit content of the copolymers. Investigations 
of varied R group hydrophobicity, repeat unit ratio and molecular mass on the antimicrobial 
activity against E. coli and on the compatibility with human keratinocytes showed that the 
polymers with the longest R groups and the lowest DMAA content were the most 
antimicrobially and the most hemolytic ones. This is in line with the biological activity of 
previously reported SMAMPs. Thus, the design concept of facial amphiphilicity was 
successfully transferred, yet, the selectivity of these polymers for bacteria over mammalian 
cells still need to be optimized. 
 
Keywords: antimicrobial polymer, bioactive polymer, copolymerization parameters, itaconic 
acid, monomer synthesis. 
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TEXT FOR ToC_ABSTRACT 
Radically facially amphiphilic. Poly(diitaconates) copy the natural blueprint for antimicrobial 
peptides, yet can be obtained by simple free radical polymerization and still maintain the 
desired facial amphiphilicity of the parent peptides. 
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1. Introduction  
Due to the continuously increasing incidence of bacterial infections caused by antibiotics-
resistant bacteria, the need for new drugs and materials that inhibit bacterial growth is more 
pressing than ever.
[1]
 Very few new antibiotic drug classes have been developed in the past 
decades. However, it was estimated that by 2050, 10 million people will die every year from 
infections with antibiotics-resistant bacteria - making antimicrobial resistance more deadly 
than cancer.
[2]
  
Synthetic Mimics of Antimicrobial Peptides (SMAMPs) are a promising substance class that 
could help relieve this problem; consequently, research on small molecule SMAMPs or 
polymer-based SMAMPs has strongly increased over the last decade.
[3]
 The SMAMP 
approach was derived from nature. SMAMPs copy the design of natural antimicrobial 
peptides (AMPs, Figure 1a).
[4]
 AMPs can be found in most organisms as part of the innate 
immune system and are crucial for the immediate response of these organisms to pathogens 
including bacteria; additionally, they activate other parts of the adaptive immune system.
[5]
 
The antimicrobial activity of AMPs results from so-called facial amphiphilicity: as a result of 
the secondary structure of the AMP backbone, the residues of the hydrophobic and cationic 
amino acids fall onto opposite faces of the molecule (Figure 1a).
[3i, 4, 6]
 This enables AMPs to 
attach with their cationic face to the negatively charged outer envelope of bacteria, where they 
aggregate and eventually permeate the cell membrane using their hydrophobic groups.
[4a, 6]
 At 
the same time, there is no such electrostatic driving force for the interaction of AMPs with 
overall charge-neutral mammalian cells, which is why AMPs selectively target bacteria and 
not the cells of their host organism.
[4a, 6]
 For the development of SMAMPs, the concept of 
facial amphiphilicity was successfully transferred to the design of antimicrobial synthetic 
molecules.
[3d, 3h, i, 3l, 7]
 In these studies, it became clear that the most important parameter to be 
controlled in SMAMPs was the regular distribution of the hydrophilic, cationic groups and the 
hydrophobic groups along the molecular backbone, as this led to SMAMPs which also had a 
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high activity against bacteria, and selectivity for bacteria over mammalian cells.
[3d, 3i, 3l, 8]
 
Small molecule-based SMAMPs are obtained in step-by-step organic synthesis, thus there is 
excellent control over structural precision.
[9]
 However, such syntheses are laborious and 
expensive. Polymer-based SMAMPs, on the other hand, can be synthesized in fewer synthetic 
steps,
[3f, g, 8b, 10]
 yet often at the expense of molecular precision. This is due to lack of 
sequence-control during the polymerization step. How regular two different monomers are 
attached to a growing SMAMP chain depends solely on their relative reactivity, i.e. on their 
copolymerization parameters. Unless these dictate alternating copolymerization, the 
polymerization outcome is random or statistical. In SMAMPs, this may lead to a local 
imbalance in the distribution of hydrophobicity, and thus to increased toxicity.
[3l, 11]
 Another 
factor that reduces structural precision of synthetic polymers compared to peptides is that they 
are typically lacking a secondary structure that pre-defines the orientation of their functional 
groups. In spite of this, some polymer-based SMAMPs showed excellent antimicrobial 
activity and cell selectivity in vitro.
[3f, 8c]
 It was hypothesized that the amphiphilic polymer-
based SMAMPs could self-assemble at the liquid-bacteria interface into an appropriate 
configuration, and thereby become membrane-active.
[10c]
 This hypothesis was substantiated 
by several studies that confirm membrane-activity of SMAMPs.
[12]
  
A regular distribution of functional groups and a better bioactivity profile of polymer-based 
SMAMPs are more easily achieved with facially amphiphilic monomers, where the 
hydrophobic and the cationic, hydrophilic group are attached to the same polymerizable unit. 
This avoids runs of hydrophobic or hydrophilic repeat units in the polymer, which are often 
observed when copolymerizing two monomers carrying a hydrophilic and a hydrophobic 
group each ('segregated units').
[3g]
 For example, Gabriel et al. compared poly(norbornenes) 
with facially amphiphilic repeat units
[8b]
 to the corresponding segregated polymers,
[3g]
 and 
found that the cell selectivity of the facially amphiphilic polymers against Gram-positive and 
Gram-negative bacteria was by far higher.
[3g]
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However, the abundance of monomers that can be independently functionalized with two 
groups without becoming unpolymerizable (or of monomers that form strictly alternating 
copolymers) is rather limited. Norbornenes are such monomers, and facially amphiphilic 
poly(norbornene) SMAMPs can be obtained fast and efficiently by ring-opening metathesis 
polymerization (ROMP).
[8b, 8d, 13]
 However, the quantitative removal of the transition-metal 
based ROMP initiator is often difficult, expensive or just not possible.
[14]
 For medical 
applications (drugs or biomaterials), this can become a regulatory issue and a product safety 
problem. While fascinating new concepts that use the ROMP initiator in catalytic amounts are 
emerging,
[15]
 these as yet lack the precision and control over molecular weight of ROMP with 
stoichiometric amounts, so that alternatives to the ROMP-based platform for SMAMPs are 
desirable. 
The aim of this work was thus to develop a metal-free platform for the synthesis of SMAMP 
polymers from facially amphiphilic itaconic acid derivatives. Itaconic acid was chosen 
because it can carry two functional groups, because it is cheap and can be obtained from 
sustainable resources, and because it can be polymerized by radical polymerization.
[16]
 
Considering that it is side product in the citric acid cycle,
[16]
 itaconic acid is a promising, non-
toxic starting point for the development of drugs and biomaterials. Unfortunately, 
homopolymerization of itaconic acid derivatives by a radical mechanism is rather slow 
compared to acrylic or methacrylic acid derivatives because itaconates have a high chain 
transfer constant.
[17]
 Diitaconate esters, particularly those with short substituents, can be 
driven to quantitative conversion within 48 h, however the molecular weights obtained remain 
low due to chain transfer.
[18]
 This situation has been improved when controlled radical 
polymerization, particularly RAFT, was used to polymerize diitaconates, as reported by 
Barner-Kowolik and also by Kamigaito.
[19]
 In these papers, polymer molecular masses (Mn) 
as high as 60 000 g mol
-1
 were reported. However, even in controlled radical 
homopolymerization of diitaconates, high chain transfer was observed.
[19b]
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However, itaconate derivates can be easily copolymerized, e.g. with styrene, methyl 
methacrylate or vinyl chloride
[20]
 to obtain poly(itaconates) with varying backbone polarity. 
To our knowledge, unsymmetrically substituted poly(itaconates) in general have so far only 
been reported twice, and in these cases the product isolation was rather laborious.
[21]
 We here 
describe a straight-forward synthesis of a series of facially amphiphilic, unsymmetrically 
disubstituted diitaconates, and their copolymerizion with with N,N-dimethylacrylamide 
(DMAA). DMAA was chosen as a co-repeat unit because it had a suitable reactivity, and 
because poly(dimethyacrylamide) (PDMAA), the homopolymer of DMAA, is protein 
repellent and biologically inert.
[22]
 Thus, the presence of DMAA repeat units in the 
poly(diitaconate-co-DMAA) SMAMPs would not compromise their biocompatibility. We 
also determined the copolymerization parameters of the diitaconate monomers in free radical 
copolymerization with either DMAA or styrene. The results indicate that these 
copolymerizations yielded statistical to slightly alternating copolymers with tunable 
antimicrobial activity, as detailed below. 
 
2. Results and Discussion  
  
System Design  
To obtain facially amphiphilic SMAMPs by metal-free polymerization, poly(itaconates) 
derivatives were targeted. The design of the poly(itaconate) SMAMPs here presented is a 
direct translation of the design concept of the previously reported, highly selective 
poly(oxonorbornene) SMAMPs:
[3f, 3k]
 (Figure 1). In both polymers, the hydrophilic (blue) and 
the hydrophobic (green) functional groups are attached via ester groups to the polymer 
backbone (black). What is particular about the itaconate system is that its two carbonyl groups 
are not equivalent. As a result, they can be selectively functionalized. This was not possible in 
the symmetric oxonorbornene monomer, where the direction of the ring opening was random. 
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Thus, at the monomer level, there is even higher structural control in the diitaconate monomer 
(Figure 1b) than in the oxonorbornene diester monomer (Figure 1c).  
 
Figure 1. Synthesis route (1 to 9) and design concept (a to c) for poly(itaconate) SMAMPs. 
The molecular structure of the highly selective poly(norbornene) SMAMPs (c) was 
transferred to the poly(diitaconate) system (9). Both polymers carry a hydrophobic (green) 
and a hydrophilic (blue) group, which are connected to the polymer backbone (black) via ester 
bonds.  
  
To obtain polymers with tunable amphiphilicity, the R group was varied from R = methyl to 
R = pentyl. Since diitaconates do not homopolymerize well, the target polymers were 
copolymers with dimethyl methacrylate (DMAA). While the diitaconate repeat units contain 
both functional groups required for bioactivity, their bioactivity profile and tunability will still 
depend on the ability to control the distribution of the diitaconate and DMAA repeat units 
along the polymer chain, i.e. on their copolymerization parameters 𝑟1 and 𝑟2. For this reason, 
the copolymerization parameters for the diitaconates with DMAA (and for comparison also 
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those of the diitaconates with styrene) were determined. Additionally, the molar ratio of 
diitaconate to DMAA was used as a further variable to tune the overall polymer 
hydrophilicity, and the molar fractions of diitaconate (with R = methyl to butyl) was varied 
from 40 mol% to 60 mol%. The effect of these variations on the bioactivity of the polymers 
was determined by testing their antimicrobial activity and cell compatibility. 
 
Synthesis of Asymmetrically Disubstituted Itaconates 
The asymmetrically disubstituted diitaconates were synthesized in a two-step process 
(Figure 1). First, itaconic anhydride 1 was ring-opened with the appropriate alcohol 2 (R = 
methyl to pentyl). The ring-opening of the anhydride 1 took place exclusively at the carbonyl 
in -position to the double bond, so that mono-itaconate 3 was obtained. This was confirmed 
by 2D-NMR spectroscopy (Heteronuclear Multiple Quantum Correlation, HMQC, and 
Heteronuclear Multiple Bond Correlation, HMBC; the 2D-spectra of compound 3, with R = 
propyl, are shown in the Supporting Information as Figures S1 and S2). The side product of 
the reaction was the symmetrically substituted diester 4. Compounds 3 and 4 could be 
separated easily during work-up by washing and extraction steps (see Experimental section). 
Interestingly, the product ratio of 3 and 4 could be tuned by adding different amounts of acid. 
The more acid was used, the more diester 4 was obtained. When the acid quantity was 
reduced to catalytic amounts, a yield of up to 80% of product 3 was obtained (Table 1). For 
the esterification in the second step, at first Steglich conditions (dicyclohexylcarbodiimide, 
DCC and a catalytic amount of N,N-dimethylaminopyridine, DMAP) were applied. However, 
these conditions only lead to low yields of the disubstituted diitaconates and a large amount of 
a side product (N-acylurea). It is a well-known problem that DCC-activated acids (O-
acylurea) rearranges intramolecularly to the corresponding N-acylurea, which then cannot 
react further to the desired product. However, this rearrangement is slow and could therefore 
be suppressed by adding stoichiometric amounts of DMAP, which then transfered the O-
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acylurea quantitatively to the reactive DMAP-amide. This intermediate reacted rapidly with 
the alcohol 5 and gave the desired asymmetrically substituted diitaconates esters 6 in good 
yiels (up to 94%, Table 1). Again, the work-up of the product consisted of simple extraction 
and filtration steps, and avoided column chromatography. 
The structures of all compounds obtained were confirmed by 
1
H-NMR, 
13
C-NMR and mass 
spectrometry. As an example, the 
1
H-NMR spectra of the mono-itaconate 3c and the 
disubstituted monomer 6c (R = propyl in both cases) are shown in Figure 2. All the peaks in 
these spectra could be assigned to the target compounds (Figure 2). When comparing the 
spectrum of compound 3c to 6c (Figures 2a and 2b) a slight shift of the double bond signals 
(H5 and H6) to lower field strengths was observed, while the methylene peak (H4) was 
unaffected. The signal positions and intensities of the other peaks (H1 to H3 and H7 to H9, 
respectively) confirmed the assumed structures and thus the attachment of the hydrophobic 
and the hydrophilic groups in each reaction step. The 
1
H- NMR, 
13
C-NMR spectra and mass 
spectra of the other mono- and diitaconates can be found in the Supporting Information 
(mono-itaconates: Figures S3 to S8 - NMR spectra, Figures S9 to S13 - mass spectra; 
diitaconates: Figures S14 to S19 - NMR spectra, Figures S20 to S24 - mass spectra).  
 
Table 1. Reaction yields for the synthesis of monoitaconates 3a to 3e, the symmetrically 
substituted diitaconates 4a to 4e, and the asymmetrically substituted diitaconates 6a to 6e. 
R group 
mono-itaconate 3 
/ % 
diester 4 
/ % 
diitaconate 6 
/ % 
Methyl a 30 25 61 
Ethyl b 75 2 94 
Propyl c 80 7 91 
Butyl d 75 14 70 
Pentyl e 28 9 78 
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Copolymerization of Diitaconates with DMAA 
To obtain the facially amphiphilic target polymers, the asymmetrically substituted 
diitaconates 6a-d were copolymerized by free radical polymerization with DMAA (7) at 
different monomer ratios using standard free radical polymerization conditions (Figure 1). 
The reaction temperature needed to be carefully adjusted, as higher temperatures (80°C and 
more) led to polymer cross-linking, and too low polymerization temperatures resulted in long 
reaction times and low monomer conversion. The optimum temperature range was 65-70°C. 
The polymer was recovered by precipitation from dichloromethane into n-hexane. 
 
Figure 2. 
1
H-NMR spectra (in CDCl3) of mono-itaconate 3c (a), the asymmetrically 
disubstituted diitaconate 6c (b), and the poly(diitaconate-co-DMMA) 8c (c) with a 
diitaconate:DMAA ratio of 1:1. The NMR signals (H1 to H11) of each spectrum could be 
assigned to the expected protons of the target structures. The signal intensities (numbers 
underneath each peak) closely matched the expected proton numbers. 
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The 
1
H-NMR spectrum of copolymer 8c with a diitaconate:DMAA ratio of 1:1 is shown in 
Figure 2c. Further 
1
H-NMR spectra of the copolymers 8a-d, with 40-60 mol% diitaconate 
content, can be found in the Supporting Information (Figures S25 to S28). The signals of H1 
to H3 and H7 to H9 in the diitaconate repeat unit remained at similar chemical shifts as the 
corresponding signals of monomer 6c (Figure 2b), albeit with the typical polymer peak 
broadening. The signal H4 of the methyl group of the DMAA repeat unit appeared slightly 
above 3 ppm. The polymer backbone protons are, expectedly, even broader than the side 
chain signals and fall into the typical regions for such aliphatic backbone protons. Gel 
permeation chromatography (GPC, calibrated with poly(methyl methacrylate) (PMMA) 
standards) was used to determine the molecular weight (number average molar mass, Mn) and 
polydispersity index (PDI) of the copolymers 8a-d with varying diitaconate content (40-60 
mol% diitaconate). A typical GPC elugram is shown in Figure3a. The GPC elugrams of the 
other polymers can be found in the Supporting Information (Figure S30); the data thus 
obtained is summarized in Table 2. 
 
 
 
Figure 3. Gel permeation chromatography (GPC) elugrams (in chloroform, flow rate: 
1 mL min
-1
, SDV columns, PMMA standards, refractive index detector intensity I vs. elution 
volume V)) of a) poly(diitaconate-co-DMAA) 8c, diitaconate:DMAA ratio 1:1, and b) 
poly(diitaconate-co-DMAA) 8c, diitaconate:DMAA ratio 1:1, with different molecular 
weights. 
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Table 2. Analytical data for polymers 8 and 9. The number average molecular mass  
𝑀𝑛 and polydispersity index PDI (= 
𝑀𝑤
𝑀𝑛
 ) of the N-Boc-protected polymers 8 were determined 
by gel permeation chromatography (GPC, in chloroform, SDV columns, calibrated with 
PMMA standards). The minimum inhibitory concentration (MIC90) against E. coli and the 
hemolytic concentration (HC50) of the corresponding deprotected copolymers 9a-d were 
determined as described in the Experimental; * = value out of experimental range, n.d. = not 
determined. 
 
Diitaconate 
content 
Polymer 
𝑴𝒏 
/ g mol
-1 
PDI Polymer 
MIC90 
/ μg mL-1 
HC50 
/ μg mL-1 
selectivity 
40 mol% 
8a 
19,100 3.0 
9a 
*, >400 *, >8000 n.d. 
50 mol% 11,900 2.6 *, >400 *, >8000 n.d. 
60 mol% 12,500 2.7 *, >400 *, >4000 n.d. 
40 mol% 
8b 
19,500 2.1 
9b 
*, >400 *, >8000 n.d. 
50 mol% 7,300 2.6 *, >400 1050 n.d. 
60 mol% 6,900 3.3 *, >400 6100 n.d. 
40 mol% 
8c 
11,200 2.5 
9c 
200 n.d. n.d. 
50 mol% 12,500 2.9 200 300 1.5 
60 mol% 6,600 3.5 100 160 1.6 
40 mol% 
8d 
24,000 3.9 
9d 
50 9 0.2 
50 mol% 17,700 2.8 25 5 0.2 
60 mol% 11,800 2.7 50 3 0.06 
50 mol% 
8c 
1,600 3.4 
9c 
*, >400 1,260 3.2 
50 mol% 4,300 1.6 200 350 1.8 
50 mol% 7,200 2.8 50 230 4.6 
50 mol% 12,500 2.9 50 300 6 
50 mol% 41,000 1.8 12.5 70 0.6 
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Reaction Conversion and Copolymerization Parameters of Diitaconate 6c and DMAA 
 
1
H-NMR spectroscopy was used to determine the monomer conversion during the 
copolymerization of diitaconate 6c with DMAA. For this purpose, nine reaction batches with 
varying ratios of diitaconate 6c (10-90 mol%) and DMAA (90-10 mol%, respectively) were 
prepared. Following a literature method,
[23]
 the conversion of each monomer over time was 
determined by calculating the relative intensity of the respective monomer peaks for each time 
point (signal at 6.26 ppm for the diitaconate, signal at 5.62 ppm for the DMAA, normalized to 
the constant signal of the added N,N-dimethylformamid standard at 8.02 ppm). The results are 
summarized in Figure 4. Figure 4a and Figure 4b show the time dependent consumption of 
the diitaconate monomer 6c and the total monomer conversion (6c + DMAA), respectively, 
for the nine different batches. From one time point with low reaction conversion each, a plot 
of the molar fraction of the diitaconate repeat units (X) in the nine copolymers vs. the molar 
fraction x of diitaconate in the monomer mixture was composed (Figure 4c). The curve is 
slightly S-shaped and bends around the diagonal line on which the repeat unit composition of 
the polymer corresponds to the composition of the monomer mixture. Thus, the 
polymerization is almost statistical. This is important for the SMAMPs synthesis, as it means 
that the monomer feed ratio approximately matches the repeat unit composition of the 
resulting polymer over a wide range of compositions. Thus, the monomer feed ratio can be 
used to tune the overall hydrophilicity of the resulting polymer. Figure 4a and Figure 4b also 
show that the monomer conversion increased with increasing amount of DMAA. This 
observation matches the results of the GPC analysis (Figure 4d and Table 3), which indicates 
that the isolated polymers also had higher average molecular masses with increasing DMAA 
content. This was expected, since DMAA homopolymerizes more easily at 70°C than the 
diitaconate. In the case of polymer 8c with 10 mol% diitaconate repeat units, the 
polydispersity index was extremely high, most likely due to formation of inter-chain cross 
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links, as the chosen polymerization time (24 h) was too long for this particular composition. 
For the other compositions, the polydispersity index ranged between 1.7 to 3.8 (Figure 4d).  
 
 
Figure 4. Copolymerization of diitaconate 6c with DMAA. The monomer composition was 
varied from 10% diitaconate and 90% DMAA (= 10 mol% in the figure) to 90% diitaconate 
and 10% DMMA (= 90 mol% in the figure). a) Conversion of the diitaconate monomer vs. 
time and b) total monomer conversion vs. time. Both data sets were determined by 
1
H-NMR 
spectroscopy. c) Plot of molar fraction X of diitaconate in the polymer vs. the molar fraction x 
of diitaconate in the monomer mixture at 12-21% total conversion. On the diagonal line, the 
repeat unit composition of the polymer corresponds to the composition of the monomer 
mixture. d) Gel permeation chromatography (GPC) elugrams (refractive index detector 
intensity I vs. elution volume V) of copolymers 8c with different monomer ratios of 
diitaconate and DMAA that were isolated at the end point of the reactions (Figure 4a). 
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Table 3. Gel permeation chromatography (GPC) data (in chloroform, SDV columns, 
calibrated with PMMA standards) for polymers 8c (obtained by copolymerization of 6c with 
DMAA), and for copolymers obtained by copolymerization of diitaconate 4c with styrene. 𝑀𝑛 
= number average molecular weight, 
𝑀𝑤
𝑀𝑛
 = polydispersity index (PDI). The polymer 
composition was varied from 10% diitaconate and 90% DMAA (=10 mol% in the table) to 
90% diitaconate and 10% DMMA (= 90 mol% in the table). 
 
Polymer 8c 
Mn 
/ g mol
-1
 
PDI Polymer 4c/styrene 
Mn 
/ g mol
-1
 
PDI 
10 mol% 124,100 12.5 10 mol% 23,400 2.3 
20 mol% 92,000 2.2 20 mol% 21,000 2.2 
30 mol% 32,000 3.8 30 mol% 20,200 1.6 
40 mol% 26,700 2.8 40 mol% 17,700 1.6 
50 mol% 22,100 2.3 50 mol% 11,200 1.8 
60 mol% 20,600 2.2 60 mol% 12,100 1.8 
70 mol% 10,100 2.0 70 mol% 8,100 1.8 
80 mol% 12,000 1.9 80 mol% 5,200 1.6 
90 mol% 8,800 1.7 90 mol% 3,800 1.4 
 
The copolymerization parameters (r-parameters), i.e. the relative reactivity of the two 
monomers, were calculated from the individual 
1
H-NMR spectra using the Fineman-Ross 
plot, the Inverted-Fineman-Ross plot and the Kelen-Tudos plot.
[23-24]
 These plots linearize the 
Mayo-Lewis equation, which is used to describe copolymerization kinetics, so that the 
copolymerization parameters can be obtained (see Supporting information, Figures S37 to 
S38). The r-parameters thus obtained are summarized in Table 4. Copolymerization 
parameters are different for each comonomer pair A and B and also temperature-dependent, 
as they are the ratios of two propagation rate constants (𝑟1 =
𝑘𝐴𝐴
𝑘𝐴𝐵
 and 𝑟2 =
𝑘𝐵𝐵
𝑘𝐵𝐴
, respectively, 
where 𝑘𝐵𝐴 (for example) is the rate constant of the addition of monomer A to a polymer with 
a chain end radical B), which are temperature-dependent themselves. Besides the 
copolymerization parameters for the reaction of 6c with DMAA, we also determined the 
    
 - 17 - 
copolymerization parameters for the reaction of 4c with styrene to have a reference data set 
for comparison with literature data (Figure S39) For the system 4c/styrene (polymerized at 
80°C), both copolymerization parameters were well below one, which indicates that the 
propagation rate of the reaction of each monomer with a like chain end (𝑘𝐴𝐴, 𝑘𝐵𝐵, 
corresponding to a 'homopolymerization' step) was slower than the propagation rate with an 
unlike chain end (𝑘𝐴𝐵 , 𝑘𝐵𝐴,  corresponding to a 'copolymerization' step). This hints at a 
tendency to form alternating copolymers rather than strictly statistical copolymers. For the 
system 6c/DMMA the polymerization temperature was set to 70°C. This was due to the 
higher overall reactivity of DMAA compared to styrene. Nevertheless, the copolymerization 
parameters for the system 6c/DMAA were similar to those of the system 4c/styrene. In both 
cases, the copolymerization parameters were below one, showing that both monomers slightly 
favored alternating copolymerization rather than forming statistical copolymers. 
 
Table 4. Copolymerization parameters 𝑟1 and 𝑟2 for the reaction of diitaconates 4c and 6c with 
styrene and DMMA respectively. 
Comonomer 1 Comonomer 2 
Reaction 
Temperature 
/ °C 
Method r1 r2 
4c styrene 
80 Fineman-Ross 0.22 0.46 
80 
Inverted Fineman-
Ross 
0.32 0.45 
80 Kelen-Tudos 0.38 0.58 
6c DMAA 
70 Fineman-Ross 0.47  0.53  
70 
Inverted Fineman-
Ross 
0.49  0.49 
70 Kelen-Tudos 0.55  0.58  
 
Tate et al.
[20]
 found copolymerization parameters for the reactions of various itaconic acid 
derivatives with different comonomers (Table 5). The r-parameters determined in this work 
were in good agreement with this data: the 𝑟1 values of the diitaconates were below 1 when 
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copolymerized with either styrene or methyl methacrylate. The r-parameters 𝑟2 of styrene in 
these systems were also below 1, indicating a statistical to alternating incorporation of both 
monomers. The literature values of 𝑟2 for reactions of diitaconates with methyl methacrylate 
were mostly above 1, which indicates a preference of methyl methacrylate for the 
homopolymerization step in these systems. For the copolymerization of (di)itaconates with 
DMAA, no copolymerization parameters were reported so far, yet the copolymerization 
parameters found for the comonomer pair 8c and DMAA in this work are reasonable. In the 
context of SMAMPs, the fact that 𝑟1 and 𝑟2 were below 1 for the investigated diitaconate-
comonomer systems, which indicates a statistical to alternating monomer incorporation, is an 
important finding. It means that there is no intrinsic tendency to an irregular repeat unit 
distribution in these polymers. Thus, there is sufficient reaction control in the polymerization 
step, and the global as well as the local molecular amphiphilicity and charge density of the 
SMAMP copolymers can be tuned by varying the R groups on the facially amphiphilic repeat 
units, and by adjusting the molar fractions of the repeat units.  
 
Table 5. Copolymerization parameters r1 and r2 for the reaction of various itaconic acid 
derivatives with different comonomers. 
Comonomer 1 Comonomer 2 𝒓𝟏 𝒓𝟐 Lit. 
4c styrene 0.41 0.25 
[25]
 
4a n-butylacrylate 0.94 0.40 
[20]
 
4a methyl methacrylate 0.3 1.3 
[20]
 
4d methyl methacrylate 0.4 0.8 
[20]
 
 
Copolymer Activation and Bioactivity  
The protected poly(diitaconate-co-DMAA) 8 copolymers were activated by removing their 
tert-butyloxycarbonyl (Boc) protective group with hydrochloric acid. This gave 
poly(diitaconate-co-DMAA) SMAMPs 9 with primary ammonium groups. They were 
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precipitated from methanol into diethyl ether and then dried. The removal of the Boc groups 
was confirmed by 
1
H-NMR spectroscopy (see Experimental section and Figure S35). The 
antimicrobial activities of the copolymers 9a-d with varying DMAA content and of polymers 
9c with varying molecular mass (at constant diitaconate:DMAA ratio of 1:1) were determined 
using the Minimum Inhibitory Concentration (MIC) assay. In this assay (described in the 
Experimental section), the MIC90 value is determined, which corresponds to the SMAMP 
concentration at which 90% bacterial growth is inhibited - the smaller this value, the more 
active the polymer. The toxicity of the copolymers was estimated by determining their 
propensity to lyse human red blood cells using and the Hemolysis assay (described in the 
Experimental section). In this assay, the hemolytic concentration HC50 (the concentration at 
which 50% of human red blood cells are lysed by the polymer) was determined - the higher 
this value, the less hemolytic the polymer. The curves thus obtained are shown in Figure 5, 
and the corresponding MIC and HC50 values are listed in Table 2. In line with the results 
obtained for the parent poly(oxanorbornene) system,
[3f]
 the highest antimicrobial activity was 
found for the more hydrophobic copolymers (with longer alkyl side chains at R, Figure 5a). 
The impact of hydrophobicity on antimicrobial activity was also seen in the series of 
polymers which had the same R groups, but different molar ratios of diitaconate and DMAA. 
As all diitaconate repeat units were more hydrophobic than DMAA, the antimicrobial activity 
of these polymers also increased with increasing diitaconate content. This was particularly 
apparent for polymer 9c (Figure 5a). A similar effect was observed in the HC50 data (Figure 
5b), which also increased with increasing hydrophobicity. These results are consistent with 
antimicrobial data of many other polymer series, where a general increase in antimicrobial 
activity with increased molecular hydrophobicity (at constant overall molecular weight) has 
been observed.
[3h, 8c, 26]
 Polymers that deviate from this trend are typically found to be less 
soluble in aqueous media, and thus less bioavailable than their more hydrophilic 
counterparts.
[3h, 8c, 26]
 The most hydrophobic copolymers (particularly 9d, with R = butyl) 
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were also the most toxic ones. The shorter the alkyl group R and the higher the DMAA 
content (at constant molecular mass), the lower was their hemolytic activity. This is also 
consistent with the trends observed for previously reported polymers.
[3h, 8c, 26]
 Thus, the design 
concept of the facially amphiphilic poly(oxonorbornenes) was successfully translated to 
poly(diitacoante-co-DMAA) copolymers mit facially amphiphilic repeat units, which were 
antimicrobially active and had tunable properties.  
For the copolymer series with different molecular weights (9c, diitaconate:DMAA ratio 1:1, 
𝑀𝑛  = 1,500 - 41,000 g mol
-1
), the antimicrobial activity increased significantly with increasing 
molecular mass of the samples tested (Figure 5c). A similar trend was also found in their 
hemolytic activity (Figure 5d). This was somewhat unexpected, as an increase of 
antimicrobial activity in this molecular weight range is typically not observed. For example, 
for amphiphilic poly(norbornene) SMAMPs, antimicrobial activity was either unaffected by 
molecular weight, or was found to decrease.
[8b]
 Likewise, the hemolytic activity of these 
polymers was independent of their molecular mass.
[8b]
 For another poly(oxonorbornene) 
SMAMP, both antimicrobial activity and hemolytic activity decrease with increasing 𝑀𝑛.
[3h, 
12c]
 However, the poly(methacrylates) reported by of Kuroda and DeGrado were consistently 
more hemolytic with increasing molecular weight, although only a narrow molecular range 
from 1,600 g mol
-1
 to 8,700 g mol
-1
 was investigated in these studies.
[26]
 For the same polymer 
series, antimicrobial activity decreased with increasing 𝑀𝑛  for the more hydrophobic 
polymers (R = propyl, butyl, benzyl), while it slightly increased for with increasing 𝑀𝑛  for the 
corresponding methyl and ethyl copolymers. For the nylon-3 random copolymers described 
by Gellman, hemolysis strongly increased with increasing polymer chain length.
[8c]
 Thus, the 
molecular weight effect on these properties, in contrast to the hydrophobicity effect, is not yet 
fully understood. 
 
 
    
 - 21 - 
 
Figure 5. Bioactivity of poly(diitaconate-co-DMAA) SMAMPS. a) Antimicrobial activity 
against E. coli bacteria and b) hemolytic activity of copolymers 9a-d with different ratios of 
diitaconate to DMAA; c) antimicrobial activity against E. coli bacteria and d) hemolytic 
activity of copolymers 9c (diitaconate:DMAA ratio 1:1) with different molecular masses. The 
data point with a growth percentage below the straight lines in a) and c) indicates the MIC90 
value; the intercept of the curves and the straight lines in b) and d) the location of the HC50 
value. 
 
 
3. Conclusions  
We here presented the synthesis and copolymerization of a series of diitaconate monomers 
from which facially amphiphilic, antimicrobial synthetic mimics of antimicrobial peptides 
(SMAMPs) could be obtained. Their design concept was adapted from facially amphiphilic 
poly(oxonorbornenes), yet they had the advantage that they could be obtained by free radical 
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polymerization, a metal free polymerization technique, and still maintained the facial 
amphiphilicity at the repeat unit level.  
Starting from itaconic anhydride, two distinct functional groups could be placed at the two 
non-equivalent carbonyl groups of that building block. Using 2D NMR techniques, it was 
shown that the functionalization of the itaconic anhydride with the first functional group 
selectively occurred at the carbonyl in -position to the double bond. By determining the 
copolymerization parameters of the diitaconate monomers with DMAA, it was shown that the 
poly(diitaconate-co-DMAA) copolymers obtained were statistical to alternating, and that the 
monomer feed ratio roughly matched the repeat unit content of the copolymers. By varying 
the overall hydrophobicity of the polymers using the length of the alkyl chain R and the 
DMAA content as parameters, it could be shown that the polymers with the longest R groups 
and the lowest DMAA content were the most antimicrobially active ones, yet they were also 
the most hemolytic ones. This is in line with the biological activity of the previously reported 
poly(oxonorbornes) and other polymer series.
[3h, 3l]
 Thus, the design concept of the facially 
amphiphilic poly(oxonorbornenes) was successfully transfered to the facially amphiphilic 
poly(diitaconate-co-DMAA) copolymers. So far, however, the selectivity of these polymers 
for bacteria over mammalian cells (Table 2) remains low due to the multitude of parameters 
that need to be further optimized in this polymer system. However, the data shows that once 
the design rules for one facially amphiphilic SMAMP system are known, these design rules 
can be transferred from one polymer system to another, provided that each system is 
synthesized with sufficient structural control. Importantly, the here described diitaconate-
based SMAMPs can be synthesized by metal free initiator systems. This eliminates the need 
for laborious metal removal during work-up and is thus advantageous for drug and 
biomaterials applications from a regulatory and product safety perspective. Additionally, it 
makes these polymers much cheaper than the corresponding poly(norbornenes), which is of 
particular importance for materials applications, where larger polymer amounts might be 
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needed. However, to be truly useful as drugs and materials, their hemolytic activity has still to 
be optimized. This can be achieved by further structural optimization, particularly by using 
other co-repeat units than DMAA. In future work we will strive for even more control in the 
polymerization of these systems. In the light of the molecular weight dependency of the 
biological activities of these polymers, the next variable to be optimized will be the 
polydispersity, using controlled radical polymerization. We will report on our progress in this 
project in due course.  
 
4. Experimental Section  
 
General 
All chemicals, e.g. itaconic anhydride, methanol, ethanol, n-propanol, n-butanol, n-pentanol, 
4-dimethylaminopyridine (DMAP), N,N’-dicyclohexylcarbodiimide (DCC), N-Boc-
ethanolamine, 2,2’-azobis(2-methylpropionitrile) (AIBN) and HPLC grade solvents, e.g. 
dichloromethane (DCM), acetone, chloroform, hexane or diethyl ether, were obtained as 
reagent grade from Sigma Aldrich (Darmstadt, Germany) or Carl Roth (Karlsruhe, Germany) 
and used as received, unless otherwise indicated. N,N-dimethylacrylamide (DMAA), DMF 
and styrene were freshly distilled before use. AIBN was recrystallized from methanol. Gel 
permeation chromatography (GPC, in chloroform, flow rate 1 ml min
-1
, calibrated with 
poly(methyl methacrylate) (PMMA) standards) was measured on a non-polar GPC column set 
(PSS SDV analytical (5 µm, 100 Å and 10.000 Å), PSS, Mainz, Germany). NMR spectra 
were recorded on a Bruker 250MHz spectrometer (Bruker, Madison, WI, USA). 
 
Synthesis of Asymmetrical Diitaconates 
Synthesis of 4-Alkyl Itaconates 3a to 3e 
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To obtain the 4-alkyl itaconates 3a to 3e with R = methyl to pentyl, itaconic anhydride (4.3 g, 
38 mmol) was dissolved in DCM (10 mL) and the required primary alcohol with the 
appropriate R group (40 mL, excess) was added. Next, H2SO4 (conc., 0.5 mL) was added, and 
the solution was stirred overnight at room temperature. DCM (50 mL) was added to the 
reaction mixture to facilitate phase separation. The organic phase was then extracted with 
aqueous K2CO3 (10 w%, 3 x 50 mL) and the aqueous phase was washed with 
DCM (3 x 50 mL). The combined organic phases were dried over Na2SO4. The solvent was 
evaporated under reduced pressure to yield the side product 4 as a yellow oil. To the aqueous 
phase, HCl (conc., 40-50 mL) was added until the pH value was 2. The aqueous phase was 
then extracted with DCM (3 x 100 mL). The organic phases were combined and dried over 
Na2SO4. The solvent was evaporated under reduced pressure and the product was dried at 
high vacuum overnight. The product was obtained as a colorless solid.  
4-Methyl itaconate 3a 
1
H-NMR (250 MHz, CDCl3, δ): 6.50 (s, 1H), 5.88 (s, 1H), 3.74 (s, 3H, CH3), 3.39 ppm (s, 2H, 
CH2); 
13
C NMR (63 MHz, CDCl3, δ): 171.97 (C=O), 171.51 (C=O), 133.60 (s, C=C), 131.33 
(s, C=C), 52.56 (C-O), 37.43 ppm (C3); MS (APCI) m/z: [M + H]
+
 calcd. for C6H8O4, 143.13; 
found, 143.03. 
4-Ethyl itaconate 3b 
1
H NMR (250 MHz, CDCl3, δ): 6.49 (s, 1H), 5.86 (s, 1H), 4.20 (td, J = 7.10 Hz, 2H, CH2), 
3.37 (s, 2H, CH2), 1.29 ppm (t, J = 7.11 Hz, 3H, CH3); 
13
C NMR (63 MHz, CDCl3, δ): 172.03 
(s, C=O), 171.07 (C=O), 133.76 (C=C), 131.10 (C=C), 61.44 (C-O), 37.70 (C3), 14.43 ppm 
(s, C6); MS (APCI) m/z: [M + H]
+
 calcd. for C7H10O4, 157.15; found, 157.05. 
4-Propyl itaconate 3c 
1
H NMR (250 MHz, CDCl3, δ): 6.49 (s, 1H), 5.87 (s, 1H), 4.10 (t, J = 6.71 Hz, 2H, CH2), 
3.38 (s, 2H, CH2), 1.68 (tq, J = 7.10 Hz, 2H, CH2), 0.96 ppm (t, J = 7.42 Hz, 3H, CH3); 
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13
C NMR (63 MHz, CDCl3, δ): 171.98 (C=O), 171.14 (C=O), 133.81 (C=C), 130.99 (C=C), 
67.04 (C-O), 37.71 (C3), 22.24 (C6), 10.63 ppm (C7). MS (APCI) m/z: [M + H]
+
 calcd for 
C8H12O4, 171.18; found, 171.06. Anal. calcd. for C8H12O4: C 55.81, H 7.02; found: C 55.47, 
H 6.58. 
4-Butyl itaconate 3d 
1
H NMR (250 MHz, CDCl3, δ): 6.48 (1H), 5.86 (1H), 4.14 (t, J = 6.56 Hz, 2H, CH2), 3.37 (s, 
2H, CH2), 1.54 - 1.76 (m, 2H, CH2), 1.40 (tq, J = 7.30 Hz, 2H, CH2), 0.95 ppm (t, J = 7.27 
Hz, 3H, CH3); 
13
C NMR (63 MHz, CDCl3, δ): 172.05 (C=O), 171.10 (C=O), 133.81 (C=C), 
130.98 (C=C), 65.30 (C5), 37.71 (C3), 30.90 (C6), 19.40 (C7), 13.97 ppm (C8); MS (APCI) 
m/z: [M + H]
+
 calcd. for C9H14O4, 185.21; found, 185.08.  
4-Pentylitaconate 3e 
1
H NMR (250 MHz, CDCl3, δ): 6.49 (1H), 5.86 (1H), 4.13 (t, J = 6.56 Hz, 2H, CH2), 3.37 (s, 
2H, CH2), 1.60 - 1.71 (m, 2H, CH2), 1.28 – 1.37 (m, 4H, CH2, CH2), 0.92 ppm (t, J = 7.27 Hz, 
3H, CH3); 
13
C NMR (63 MHz, CDCl3, δ): 170.60 (C=O), 171.13 (C=O), 133.84 (C=C), 
130.71 (C=C), 65.48 (C5), 37.61 (C3), 28.49 (C6), 28.27 (C7), 22.55 (C8), 14.14 ppm (C9); 
MS (APCI) m/z: [M + H]
+
 calcd. for C10H16O4, 200.23; found, 200.11.  
 
Synthesis of 1-(N-Boc-2’-aminoethyl) 4-alkyl diitaconate 6a to 6e 
The reaction was performed under nitrogen atmosphere. N-Boc-ethanolamine (1.3 g, 
7.9 mmol, 1.2 eq) and DMAP (1.2 g, 9.9 mmol, 1.5 eq) were added to a solution of the 
appropriate 4-alkylitaconate 3a to 3e (6.6 mol, 1 eq) in DCM (10 mL). The solution was 
cooled with ice for 10 min, then DCC (1.5 g, 7.3 mmol, 1.5 eq) in DCM (10 mL) was added 
dropwise. The reaction vessel was stirred overnight at room temperature. The reaction 
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mixture was then filtered and washed with aqueous KHSO4 (10 w%, 3 × 100 mL) and 
aqueous NaHCO3 (saturated, 2 × 100 mL). The organic phase was dried over Na2SO4, and the 
solvent was removed under reduced pressure. The resulting product was diluted in DCM 
(5 mL) and stored in the freezer overnight to get rid of left-over urea side product, which 
precipitated. After the cold liquid phase was filtered to remove the precipitate, the solvent was 
evaporated under reduced pressure and the product was dried at high vacuum overnight. 
 
1-(N-Boc-2’-aminoethyl) 4-methyl diitaconate 6a 
1
H NMR (250 MHz, CDCl3, δ): 6.35 (s, 1H), 5.72 (s, 1H), 4.94 (br. s, 1H), 4.22 (t, J = 5.21 
Hz, 2H, CH2), 3.71 (s, 3H, CH3), 3.41 (tq, J = 5.20 Hz, 2H, CH2), 3.35 (s, 2H, CH2), 1.44 ppm 
(s, 9H, (CH3)3); 
13
C NMR (63 MHz, CDCl3, δ): 171.68 (s, C=O), 166.23 (C=O), 156.15 
(C=O), 133.92 (s, C=C), 129.47 (C=C), 79.83 (C-(CH3)3), 64.74 (C4’), 52.45 (C5), 39.92 
(C5’), 37.96 (C3), 28.72 ppm (C-(CH3)3); MS (ESI) m/z: [M + Na]
+
 calcd. for C13H21NO6, 
310.31; found 310.12. 
 
1-(N-Boc-2’-aminoethyl) 4-ethyl diitaconate 6b 
1
H NMR (250 MHz, CDCl3, δ): 6.39 (s, 1H), 5.75 (s, 1H), 4.92 (br. s., 1H), 4.26 (t, J = 5.30 
Hz, 2H, CH2), 4.20 (q, J = 7.20 Hz, 2H, CH2), 3.46 (td, J = 5.30 Hz, 2H, CH2), 3.37 (s, 2H, 
CH2), 1.47 (s, 9H, (CH3)3), 1.30 ppm (t, J = 7.19 Hz, 3H, CH3); 
13
C NMR (63 MHz, CDCl3, 
δ): 171.25 (C=O), 166.30 (C=O), 156.16 (C=O), 134.06 (C=C), 129.31 (C=C), 79.81 
(C-(CH3)3), 64.76 (C4’), 61.37 (C5), 39.94 (C5’), 38.23 (C3), 28.73 (C (CH3)3), 14.51 ppm 
(C6); MS (ESI): m/z = [M+Na]
+
 calcd. for C14H23NO6, 324.34; found 324.14. 
 
1-(N-Boc-2’-aminoethyl) 4-propyl diitaconate 6c 
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1
H NMR (250 MHz, CDCl3, δ): 6.38 (s, 1H), 5.75 (s, 1H), 4.92 (br. s., 1H), 4.25 (t, J = 
5.20 Hz, 2H, CH2), 4.10 (t, J = 6.70 Hz, 2H, CH2), 3.46 (td, J = 5.20 Hz, 2H, CH2), 3.39 (s, 
2H, CH2), 1.69 (tq, J=7.10 Hz, 2H, CH2), 1.47 (s, 9H, (CH3)3), 0.96 ppm (t, J = 7.35 Hz, 3H, 
CH3);  
13
C NMR (63 MHz, CDCl3, δ): 171.35 (C=O), 166.33 (C=O), 156.18 (C=O), 134.08 (C=C), 
129.32 (C=C), 79.84 (C-(CH3)3), 66.99 (C5), 64.81 (C4’), 39.93 (C5’), 38.24 (C3), 28.73 (s, 
C-(CH3)3), 22.27 (C6), 10.69 ppm (C7); MS (APCI) m/z: [M + H]
+
 calcd. for C15H25NO6, 
316.37; found, 316.17. Anal. calcd for C15H25NO6: C 57.13, H 7.99, N 4.44; found: C 57.16, 
H 7.45, N 4.43. 
 
1-(N-Boc-2’-aminoethyl) 4-butyl diitaconate 6d 
1
H NMR (250 MHz, CDCl3, δ): 6.26 (s, 1H), 5.64 (s, 1H), 5.05 (br. s., 1H), 4.13 (t, J = 
5.29 Hz, 2H, CH2), 4.03 (t, J = 6.63 Hz, 2H, CH2), 3.33 (td, J = 5.20 Hz, 2H, CH2), 3.27 (s, 
2H, CH2), 1.45 - 1.62 (m, 2H, CH2), 1.36 (s, 9H, (CH3)3), 1.19 - 1.34 (m, 2H, CH2), 0.84 ppm 
(t, J = 7.20 Hz, 3H, CH3); 
13
C NMR
 
(63 MHz, CDCl3, δ): 171.20 (C=O), 166.24 (C=O), 
156.15 (C=O), 134.08 (C=C), 129.09 (C=C), 79.62 (C-(CH3)3), 65.13 (C5), 64.65 (C4’), 
39.84 (C5’), 38.10 (C3), 30.87 (C6), 28.65 (C-(CH3)3), 19.34 (C7), 13.93 ppm (C8); MS 
(ESI): m/z = [M+Na]
+
 calcd. for C16H27NO6, 352.39; found 352.17. 
 
1-(N-Boc-2’-aminoethyl) 4-pentyl diitaconate 6e 
1
H NMR (250 MHz, CDCl3, δ): 6.37 (s, 1H), 5.74 (s, 1H), 4.94 (br. s., 1H, NH), 4.24 (t, J = 
5.29 Hz, 2H, CH2), 4.12 (t, J = 6.63 Hz, 2H, CH2), 3.46 (td, J = 5.20 Hz, 2H, CH2), 3.37 (s, 
2H, CH2), 1.46 (s, 9H, (CH3)3), 1.28 - 1.36 (m, 6H, 3 × CH2), 0.92 ppm (t, J = 7.20 Hz, 3H, 
CH3); 
13
C NMR
 
(63 MHz, CDCl3, δ): 171.34 (C=O), 166.33 (C=O), 156.18 (C=O), 134.08 
(C=C), 129.29 (C=C), 79.89 (C-(CH3)3), 65.59 (C5), 64.83 (C4’), 38.25 (C5’), 35.30 (C3), 
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28.75 (C6), 28.36 (C-(CH3)3), 22.65 (C7), 14.68 (C8), 14.31 ppm (C9); MS (ESI): m/z = 
[M+Na]
+
 calcd. for C17H29NO6, 366.42; found 366.19. 
 
Copolymerizations 
Copolymerization of 1-(N-Boc-2’-aminoethyl) 4-alkyl diitaconates) 6a to 6e with DMAA at 
different ratios. 
The itaconate monomers were copolymerized under nitrogen atmosphere. The different 
reagent amounts for the synthesis of each polymer with different comonomer ratios or 
different molecular weights are listed in Table S1. In a typical reaction, the diitaconate 
monomer 6, e.g. 6c, and DMMA were dissolved in DMSO to obtain a total monomer 
concentration of 0.5 g mL
-1
. Next, the initiator AIBN was added. The reaction mixture was 
degassed by three freeze-pump-thaw cycles and placed into a pre-heated oil bath (bath 
temperature: 70°C) for 24 hours. The polymerized mixture was then precipitated into n-
hexane (150 mL). The precipitate was re-dissolved in DCM (15 mL) and again precipitated 
into n-hexane (150 mL). This was repeated until no more monomer peaks were observed in 
the 
1
H-NMR spectrum. The thus obtained copolymer 8 (8c in this case) was dried under high 
vacuum. 
 
Poly(1-(N-Boc-2’-aminoethyl) 4-propyl diitaconate) 8c (50 mol% 6c, 50 mol% DMAA): 
1
H NMR (250 MHz, CDCl3, δ): 4.01 (br. s, 4H, CH2, CH2), 3.39 (br. s, 2H, CH2), 3.08 (br. s, 
2H, CH2), 2.23 (br. s, 2H, CH2), 2.90 (br. s, 3H, CH2, CH), 1.70 (s, 2H, CH2), 1.46 (s, 9H, 
(CH3)3), 0.95 ppm (br. s, 3H, CH3). 
For the other molar ratios, the chemical shifts of the peaks in the 
1
H-NMR spectra were 
identical, only the peak ratios were different. The 
1
H-NMR spectra of these polymers are 
shown in Figures S25 to S28 of the Supporting Information. The chemical shifts of the peaks 
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in the 
1
H-NMR spectra of copolymer 8c with different molecular weight were identical to 
copolymer 8c which is shown in Figure S27. The Gel permeation chromatography elugrams 
for these polymers are summarized in Table 2 and shown in Figures S30, S33). 
 
Deprotection of the Copolymers  
The removal of the tert-Butyloxycarbonyl protecting group was carried out under nitrogen 
atmosphere. The respective polymer was diluted in MeOH (anhydrous, 3 mL). Then HCl (4M 
in dioxane, 3 mL) was added. The solution was stirred overnight, and the solvent was 
removed under reduced pressure. The copolymer 8 was dissolved in DCM (10 mL) and 
repeatedly precipitated into n-hexane (100 mL). The copolymer was then dried in high 
vacuum overnight to yield the deprotected copolymers 9a-d.  
1
H-NMR (250 MHz, CDCl3, δ): 8.63 (br. s., 1 H), 4.01 (br. s., 1 H), 2.92 (br. s., 7 H), 2.20 (s, 
1 H), 1.99 (br. s., 4 H), 1.66 (br. s., 3 H), 1.28 (s, 2 H), 0.95 ppm (br. s., 3 H). The 
1
H-NMR 
spectra of the deprotected polymers 9a-d with 50 mol% diitaconate are shown in Figure S29 
of the Supporting Information. For the other molar ratios, the position of the peaks in the 
1
H-
NMR spectra were identical, only the peak ratios differ. The chemical shifts of the peaks in 
the 
1
H-NMR spectra of copolymer 8c with different molecular weight were identical to 
copolymer 8c which is shown in Figure S29. 
 
Determination of the r-parameters  
To determine the r-parameters, the itaconate monomers were copolymerized under nitrogen 
atmosphere in DMSO-d6, so that the crude reaction mixture could be directly used to 
determine the monomer conversion by 
1
H-NMR spectroscopy. DMF was added as a standard 
to determine the conversion of the comonomers at different time points. The different 
amounts of reagents used for these polymerizations can be found in Tables S2 and S3 in the 
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Supporting Information. For a typical copolymerization, all reagents were dissolved in 
DMSO-d6 at a total monomer concentration of 4 mmol mL
-1
, to which the initiator AIBN was 
added. The monomer ratio was varied from 10 mol% diitaconate to 90 mol% diitaconate. The 
reaction mixture was degassed by three freeze-pump-thaw cycles. 0.5 mL of the reaction 
mixture was then filled into the required number of NMR tubes, which had been kept under 
inert atmosphere (one tube per time point). One NMR spectrum of each sample was measured 
before heating. The samples were then immersed into a pre-heated oil bath at the required 
temperature. After the required reaction times, one tube per monomer composition was 
removed and the reaction was quenched by cooling and exposing the reaction mixture to 
atmospheric oxygen. After that, the NMR spectrum of the sample was measured. After 24 
hours, the samples were precipitated first from DMSO, then from ethanol or acetone into 
n-hexane several times. The thus purified copolymer was analyzed by 
1
H-NMR spectroscopy 
and gel permeation chromatography. 
 
Minimum Inhibitory Concentration (MIC) 
The MIC is defined as the lowest concentration of a substance that can fully inhibit the 
growth of bacteria under defined conditions. For practical reasons, we here report the MIC90, 
i.e. the concentration at which 90% of bacterial growth was inhibited by the SMAMP 
polymers. This was tested the Gram-negative E. coli bacteria (ATCC25922) as reported 
previously.
[12d]
 In short, an overnight culture of the bacteria in Mueller-Hinton broth medium 
(MHB) was prepared and adjusted to a bacterial cell density of 10
6
 colony forming units 
(CFU) per mL. The respective volumes of each MHB bacterial culture were placed in a 96-
well microtiter plate with a multi-channel pipette (Eppendorf, Wesseling-Berzdorf, Germany). 
The tested polymers were diluted with dimethyl sulfoxide (DMSO, Sigma, Steinheim, 
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Germany) to the desired concentration, and added to the appropriate wells. These were filled 
to a total volume 200 µL with MHB medium, so that a polymer concentration series from 400 
µg mL
-1
 to 6.25 µg mL
-1 
in MHB was obtained. A negative control ("no growth" control, 
bacteria in MHB + isopropanol), a positive control ("growth control", bacteria with MHB 
medium only), and a black well were also prepared. The 96-well plates were incubated for 18 
h at 37 ºC in an aerobic atmosphere with 5% CO2 and no agitation. Afterwards, the optical 
density (OD) of each well at 595 nm was measured using a Tecan Infinite 200 plate-reader 
(Tecan, Crailsheim, Germany).
[12d, 27]
 The results of the MIC assay (bacterial growth versus 
polymer concentration) are shown in Figure 5; the MIC90 values are listed in Table 2. 
Hemolytic Assay (HC) 
Human red blood cells (erythrocytes) were obtained from the full blood of volunteers who 
have given their informed written consent in accordance to the guidelines of the World 
Medical Association Declaration of Helsinki; this was approved by the institutional ethics 
committee (Ethik-Kommission der Albert-Ludwigs-Universität Freiburg, Germany, vote 
number 381/15). In the hemolysis assay, lysis of human red blood cells caused by various 
concentrations of the test polymer is measured to determine the hemolytic concentration 
HC50, where 50% of the blood cells are lysed by the polymer. The haemolysis experiments 
were performed as described by Mowery et al. with minor modifications.
[12d, 28]
 In short, 
human erythrocytes (RBCs) were isolated from fresh blood to obtain a solution of 2% v/v 
RBCs in Tris-buffered saline (TBS). SMAMP solutions DMSO (80 mg mL
-1
) were diluted 
with TBS in a 96-well plate to obtain a concentration series of 8000 µg mL
-1
 to 40 µg mL
-1
 
SMAMP in DMSO/TSB. Melittin was used as a positive control (100% hemolysis), and 50 
µL TBS as control (blank). 50 µL of the 2% RBC solution were added to each well containing 
50 µL polymer solution or control. As another positive control, TritonX-100, another known 
hemolytic agent, was used.
[29]
 The plate was incubated for 1 hour at 37°C, and the supernatant 
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was pipetted into a new 96-well plate to measure its optical density (OD) at 414 nm on a 
Tecan Infinite 200 plate-reader (Tecan, Crailsheim, Germany). The relative percentage of 
RBC lysis was plotted vs. concentration, as shown in Figure 5. The HC50 values are listed in 
Table 2. 
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